From: The risk factors for tuberculosis in liver or kidney transplant recipients
Characteristics | Cases (n = 45) | Controls (n = 45) | P |
---|---|---|---|
Univariate analysis | Â | Â | Â |
 Age, mean years ± SD | 37.9 ± 10.0 | 37.8 ± 10.0 | 0.974 |
 Gender, number of male/number of female | 34/11 | 34/11 | - |
 Donor type, Deceased/the others | 32/13 | 22/23 | 0.031 |
 The type of transplantation, Liver/Kidney | 2/43 | 2/43 | - |
 Two or more transplants | 4 | 4 | 1.000 |
 Tacrolimus/Cyclosporine | 34/10 | 34/11 | 0.849 |
 Use of antilymphocytic agents | 7 | 14 | 0.081 |
 Preoperative evidence of latent TB1 | 17 | 5 | 0.003 |
 Diabetes mellitus | 7 | 7 | 1.000 |
 Rejection, n (%) | 15 | 13 | 0.649 |
 CMV infection | 18 | 5 | 0.012 |
 HCV, HBV | 10 | 10 | 1.000 |
 Major infection2 | 13 | 16 | 0.499 |
Multivariate analysis | OR | (95% CI) | Â |
 Graft from a cadaveric donor | 3.7 | (1.4-10.0) | 0.010 |
 Preoperative evidence of latent TB | 6.8 | (2.0 - 22.7) | 0.002 |